Special Issue "Anti-inflammatory Activity of Plant Polyphenols"
Deadline for manuscript submissions: 30 September 2019.
Prof. Dr. Mario Dell'Agli
Inflammation is the first body response to infection or injury, and is critical for both innate and adaptive immunity. It can be considered as part of the complex biological response of vascular tissues to harmful stimuli, such as pathogens, damaged cells, or irritants. Uncontrolled inflammation often results in chronic diseases, such as gastritis, arthritis, autoimmune disorders, degenerative joint diseases, rheumatisms, atherosclerosis, diabetes, and even cancer. The inflammatory process is characterized by migration of immune cells from blood vessels to the site of inflammation, with massive release of pro-inflammatory mediators, including cytokines, chemokines, prostaglandins, leukotrienes, and oxidative agents.
The search for new strategies, able to interfere with these mechanisms by preventing a prolonged inflammation, would greatly benefit large number of subjects. In this respect, the plant kingdom has developed a multitude of secondary metabolites, many of which are recognized as useful tools for the maintenance of human health. Several botanicals from edible or medicinal plants are widely consumed all over the world for health purposes, as different types of products, including herbal medicinal products, plant food supplements, and functional foods. The purpose of this Special Issue is to collect new findings on the anti-inflammatory activity of polyphenols from plants, as individual compounds or as ingredients of extracts, focusing mostly on their effects on the inhibition of pro-inflammatory mediators and their mechanism of action. Both in vitro and in vivo studies are welcome.
Prof. Dr. Mario Dell'Agli
Dr. Enrico Sangiovanni
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Plant polyphenols
- transcription factors
- pro-inflammatory mediators
- secondary metabolites